Medication-Aware Financial Exploitation Detection for Alzheimer’s Patients Using Edge-Aware Interaction Risk Modeling
Farzana Akter, Lisan Al Amin, Rakib Hossain, Chaitanya Gunupudi, Faisal Quader · 2026
Read Medication-Aware Financial Exploitation Detection for Alzheimer’s Patients Using Edge-Aware Interaction Risk Modeling by Farzana Akter, Lisan Al Amin, Rakib Hossain, Chaitanya Gunupudi, Faisal Quader (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2606-00672.txt.
Introduction
Akter and co-authors aim to catch financial abuse of people with Alzheimer's disease. Such abuse often spikes when a patient's mind is less steady. Standard fraud tools watch money moves alone and miss health cues that change the risk. This 2026 paper adds one such cue: whether patients take their drugs on time.
The team builds a hybrid simulated dataset for 180 patients over 45 days. It holds 8,100 drug records and 30,855 transactions. They test three models that weigh odd amounts, new vendors, pace, timing, and drug lapses. The money-only model scores best overall, the authors report. But the model that links drug lapses to risk catches far more abuse in weak windows. Its recall there rises from 0.7442 to 0.9070. The lesson is that drug lapses work best as context for risk, not as a lone signal.
Catalog record
| CREATOR | Farzana Akter, Lisan Al Amin, Rakib Hossain, Chaitanya Gunupudi, Faisal Quader |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| LICENSE | http://creativecommons.org/publicdomain/zero/1.0/ |
| RIGHTS | CC0 |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2606.00672
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Medication-Aware Financial Exploitation Detection for Alzheimer’s Patients Using Edge-Aware Interaction Risk Modeling Farzana Akter, Lisan Al Amin, Rakib Hossain, Chaitanya Gunupudi, Faisal Quader Abstract Financial exploitation is a growing concern for people with Alzheimer’s disease, especially during periods of reduced cognitive stability. Conventional fraud detection systems usually rely on financial behavior alone and ignore clinically relevant factors that may alter vulnerability. This paper proposes a medication-aware framework that synchronizes medication adherence with transaction-level monitoring to improve detection of cognitively risky financial events. A hybrid simulation dataset was constructed for 180 patients across 45 days, producing 8,100 medication records and 30,855 transactions. The framework evaluates amount anomaly, vendor novelty, transaction frequency, time deviation, and medication adherence through financial-only, additive medication-aware, and interaction-aware logistic models. Results show that the financial-only baseline obtained the highest global F1-score of 0.5000, but the interaction-aware model improved recall during medication-induced vulnerability windows from 0.7442 to 0.9070 and achieved the highest average precision for ranked high-risk cases. The findings suggest that medication adherence is most useful as a contextual modifier of financial risk rather than as an isolated predictor. 1 Introduction Financial exploitation is a major threat for older adults in digital banking and remote transaction environments. Recent work shows that financial harm in later life is shaped by both external deception and age-related changes in cognition, affect, and judgment [ 7 ] . This concern is amplified in Alzheimer’s disease, where impaired executive function and declining self-monitoring can reduce a patient’s ability to recognize abnormal transactions or respond to manipulation. Cognitive decline can also affect financial capacity before patients fully recognize the decline themselves. Mazzonna and Peracchi showed that severe cognitive decline combined with poor awareness is associated with meaningful financial losses [ 12 ] . This implies that exploitation detection for Alzheimer’s patients should not be treated only as a standard anomaly detection problem. It should also consider temporally changing vulnerability, because the same transaction may deserve different interpretation when the patient is clinically unstable. Digital dementia-care research has made progress in voice assistance, personalization, smart assistants, and remote monitoring [ 19 , 21 , 17 , 15 ] . Privacy and governance studies further show that dementia-related monitoring must minimize unnecessary exposure of sensitive personal information [ 4 , 13 ] . However, these advances do not directly solve the financial protection problem. Existing systems often focus on communication, caregiving, behavioral monitoring, or general agentic support rather than medication-aware transaction risk modeling [ 6 , 5 , 9 ] . At the same time, research on dementia and financial capacity confirms the importance of early financial markers but rarely integrates dynamic clinical context into transaction-level detection [ 8 , 16 , 18 ] . This paper addresses this gap by developing a simulation-based, medication-aware framework for financial exploitation detection. Medication non-adherence is modeled as a dynamic vulnerability signal, not as a static patient descriptor. The study asks whether financial anomalies become more informative when interpreted during missed-medication windows. The objective is not to claim live clinical or banking deployment, but to test whether medication-aware interaction modeling improves vulnerability-sensitive detection compared with financial-only and additive baselines. The contributions are fourfold. First, the paper introduces a medication-aware risk modeling framework that treats adherence as a contextual modifier of financial risk. Second, it constructs a synchronized hybrid dataset linking daily medication events with transaction streams. Third, it compares interpretable weighted scoring with logistic baselines and an interaction-aware model. Fourth, it evaluates performance both globally and inside medication-induced vulnerability windows, where missed exploitation events are most clinically concerning. 2 Related Work and Research Gap Financial exploitation among older adults has been studied across fraud, aging, cognition, and decision making. Ebner et al. showed that older adults may face deception risks because of changes in social judgment and affective processing [ 7 ] . Studies of cognitive decline and financial capacity further suggest that financial behavior can reveal early functional deterioration and neurocognitive risk [ 12 , 8 , 16 ] . Uncertainty-aware financial risk modeling also supports the need for defensible and interpretable risk estimates in compliance-sensitive settings [ 3 ] . Recent reviews confirm that financial exploitation among people living with dementia is a growing problem requiring preventive intervention [ 18 ] . However, most existing work does not treat medication adherence as a time-varying vulnerability signal. Prior studies often model vulnerability as a stable person-level condition, although Alzheimer’s-related risk may fluctuate with medication routines, fatigue, sleep, caregiver availability, and daily disruption. Medication adherence is therefore clinically relevant because missed medication can indicate reduced routine stability or periods of cognitive vulnerability. Olchanski et al. showed that Alzheimer’s medication use and adherence vary across patient populations [ 14 ] . Related machine learning work on opioid patient classification also demonstrates that medication-linked clinical data can support meaningful risk stratification [ 2 ] . In this context, a missed dose may not directly cause fraud, but it can change how moderate financial anomalies should be interpreted. AI-supported dementia-care systems provide useful technical context. LLM-based and memory-coordinated assistants have been proposed for communication and personalization in older-adult care [ 19 , 21 ] . Co-designed smart assistants, context-aware mobile systems, and remote monitoring reviews also show that AI-enabled dementia support is increasingly feasible [ 17 , 15 , 6 ] . Risk-controlled AI support for vulnerable users reinforces the need for safety-aware design, interpretability, and human oversight [ 11 ] . Agentic dementia-care frameworks suggest broader coordination possibilities, but they remain architectural rather than empirical studies of medication-aware financial risk [ 5 , 9 ] . Privacy-aware monitoring is also essential. Privacy-preserving clinical learning, including hybrid federated and split learning, provides a relevant path for sensitive patient-centered prediction without unrestricted centralized data exposure [ 1 ] . Reviews of IoMT privacy in Alzheimer’s care emphasize consent, governance, and data minimization [ 4 ] , while privacy-protecting video-based risk detection shows that useful monitoring should not require full exposure of raw personal data [ 13 ] . Participatory work on deepfake scams and older adults further shows that protection should preserve autonomy and dignity rather than simply block activity [ 20 ] . These principles support an edge-aware design in which medication and transaction signals are converted into limited risk features before escalation. The research gap is therefore clear: prior work links dementia to financial vulnerability and supports context-aware dementia monitoring, but it rarely tests whether medication adherence improves transaction-level exploitation detection. This study addresses that gap by comparing financial-only, additive medication-aware, and interaction-aware formulations under controlled simulation. 3 Methodology 3.1 Framework Overview The proposed framework synchronizes medication adherence records with financial transactions for Alzheimer’s patients. It contains three layers: a perception layer that captures medication and transaction events, a reasoning layer that converts them into aligned risk features, and an action layer that produces risk scores for review or escalation. The framework is edge-aware because it uses compact features rather than raw clinical or banking histories, which is consistent with privacy-sensitive dementia monitoring principles [ 4 , 13 ] . Figure 1 shows the overall architecture. Figure 1: Proposed medication-aware financial exploitation detection framework. Medication adherence and transaction streams are temporally synchronized to construct clinically informed financial risk representations. The